Advertisement
Advertisement
CRL
Charles River Laboratories International, Inc.
189.19
USDSponsored
+5.49
+2.99%
Feb 06, 15:59 UTC -5
Closed
After-Market
189.18
-0.01
-0.01%
CRL Earnings Reports
Positive Surprise Ratio
CRL beat 39 of 39 last estimates.
100%
Next Report
Date of Next Report
Feb 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
$996.87M
/$2.36
Implied change from Q3 25 (Revenue/ EPS)
-0.79%
/-2.88%
Implied change from Q4 24 (Revenue/ EPS)
-0.57%
/-11.28%
Charles River Laboratories International, Inc. earnings per share and revenue
On Nov 05, 2025, CRL reported earnings of 2.43 USD per share (EPS) for Q3 25, beating the estimate of 2.36 USD, resulting in a 2.88% surprise. Revenue reached 1.00 billion, compared to an expected 1.00 billion, with a 0.42% difference. The market reacted with a -5.71% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of 2.36 USD, with revenue projected to reach 996.87 million USD, implying an decrease of -2.88% EPS, and decrease of -0.79% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
What were Charles River Laboratories International, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Charles River Laboratories International, Inc. reported EPS of $2.43, beating estimates by 2.88%, and revenue of $1.00B, 0.42% above expectations.
How did the market react to Charles River Laboratories International, Inc.'s Q3 2025 earnings?
The stock price moved down -5.71%, changed from $177.85 before the earnings release to $167.70 the day after.
When is Charles River Laboratories International, Inc. expected to report next?
The next earning report is scheduled for Feb 18, 2026.
What are the forecasts for Charles River Laboratories International, Inc.'s next earnings report?
Based on 15
analysts, Charles River Laboratories International, Inc. is expected to report EPS of $2.36 and revenue of $996.87M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement